Epsilogen’s VP Biology will attend the Champions Translational Oncology Symposium on 20 March 2024, to discuss the use of IgE-based antibodies to treat cancer.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.